{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:33:59Z","timestamp":1768800839177,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bioorg.2020.103999","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T11:24:26Z","timestamp":1591615466000},"page":"103999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Synthesis and computational studies of highly selective inhibitors of human recombinant tissue non-specific alkaline phosphatase (h-TNAP): A therapeutic target against vascular calcification"],"prefix":"10.1016","volume":"101","author":[{"given":"Hina","family":"Andleeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzammal","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda","family":"Abida Ejaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Sevigny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Farman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoom","family":"Yasinzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103999_b0005","unstructured":"https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) accessed on 28-10-2019."},{"key":"10.1016\/j.bioorg.2020.103999_b0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bioorg.2020.103999_b0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/med.1010","article-title":"Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy","volume":"21","author":"Wallin","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2020.103999_h0020","doi-asserted-by":"crossref","first-page":"v59","DOI":"10.1093\/ndt\/gfh1058","article-title":"Vascular calcification in patients with end-stage renal disease","volume":"19","author":"Floege","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bioorg.2020.103999_h0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ki.2009.126","article-title":"Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?","volume":"76","author":"Krueger","year":"2009","journal-title":"Kidney. Int."},{"key":"10.1016\/j.bioorg.2020.103999_b0025","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bioorg.2020.103999_b0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jbmr.2420","article-title":"Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification","volume":"30","author":"Sheen","year":"2015","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bioorg.2020.103999_b0035","series-title":"Mammalian Alkaline Phosphatases. From Biology to Applications in Medicine and Biotechnology","author":"Mill\u00e1n","year":"2006"},{"key":"10.1016\/j.bioorg.2020.103999_b0040","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.2004080694","article-title":"Reduced plasma pyrophosphate levels in hemodialysis patients","volume":"16","author":"Lomashvili","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bioorg.2020.103999_b0045","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","article-title":"Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization","volume":"99","author":"Hessle","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2020.103999_b0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002499","article-title":"Transgenic overexpression of Tissue-Nonspecific Alkaline Phosphatase (TNAP) in vascular endothelium results in generalized arterial calcification","volume":"4","author":"Savinov","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bioorg.2020.103999_b0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2017.03.030","article-title":"Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients","volume":"260","author":"Panh","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bioorg.2020.103999_b0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/eci.12752","article-title":"Alkaline phosphatase and prognosis in patients with coronary artery disease","volume":"47","author":"Ndrepepa","year":"2017","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2020.103999_b0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcmg.2017.03.005","article-title":"Coronary artery calcification: from mechanism to molecular imaging","volume":"10","author":"Nakahara","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.bioorg.2020.103999_b0070","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.ATV.0000154774.71187.f0","article-title":"Chondrogenesis mediated by PP i depletion promotes spontaneous aortic calcification in NPP1\u2212\/\u2212 Mice","volume":"25","author":"Johnson","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bioorg.2020.103999_b0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.289.5477.265","article-title":"Role of the mouse ank gene in control of tissue calcification and arthritis","volume":"289","author":"Ho","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2020.103999_b0080","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0002-9440(10)63208-7","article-title":"Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank","volume":"164","author":"Harmey","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioorg.2020.103999_b0085","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1359\/jbmr.060619","article-title":"Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2\u2212\/\u2212 Mice","volume":"21","author":"Harmey","year":"2006","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bioorg.2020.103999_b0090","first-page":"261","article-title":"Calcification in atherosclerosis, I. Human studies","volume":"2","author":"Tanimura","year":"1986","journal-title":"J. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2020.103999_b0095","first-page":"275","article-title":"Calcification in atherosclerosis. II. Animal studies","volume":"2","author":"Tanimura","year":"1986","journal-title":"J. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2020.103999_b0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s002239900264","article-title":"Stable transfection of nonosteogenic cell lines with tissue nonspecific alkaline phosphatase enhances mineral deposition both in the presence and absence of \u03b2-Glycerophosphate: possible role for alkaline phosphatase in pathological mineralization","volume":"60","author":"Hui","year":"1997","journal-title":"Calcif. Tissue. Int."},{"key":"10.1016\/j.bioorg.2020.103999_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.RES.0000026421.61398.F2","article-title":"Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells","volume":"91","author":"Shioi","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bioorg.2020.103999_b0110","first-page":"353","article-title":"Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity","volume":"14","author":"Mathieu","year":"2005","journal-title":"J. Heart. Valve. Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2020.103999_b0115","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1038\/s41598-018-29432-4","article-title":"Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma","volume":"8","author":"Azpiazu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2020.103999_b0120","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1021\/jm900383s","article-title":"Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP)","volume":"52","author":"Dahl","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103999_b0125","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ejmech.2016.11.036","article-title":"Synthesis, alkaline phosphatase inhibition studies and molecular docking of novel derivatives of 4-quinolones","volume":"126","author":"Miliutina","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.103999_h0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389557515666150219115141","article-title":"Ecto-nucleotidase inhibitors: recent developments in drug discovery","volume":"15","author":"Baqi","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2020.103999_h0140","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.bcp.2004.07.045","article-title":"Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease","volume":"68","author":"S\u00e1nchez de Medina","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103999_h0145","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1071\/CH12134","article-title":"Synthesis, acetylcholinesterase and alkaline phosphatase inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives","volume":"65","author":"Khan","year":"2012","journal-title":"Aust. J. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.103999_h0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14756366.2018.1428193","article-title":"Tricyclic coumarin sulphonate derivatives with alkaline phosphatase inhibitory effects: in vitro and docking studies","volume":"33","author":"Iqbal","year":"2018","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2020.103999_h0155","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3390\/molecules15053010","article-title":"Assay format as a critical success factor for identification of novel inhibitor chemotypes of tissue-nonspecific alkaline phosphatase from high-throughput screening","volume":"15","author":"Chung","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.103999_h0160","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1359\/JBMR.040608","article-title":"Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase","volume":"19","author":"Kozlenkov","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bioorg.2020.103999_h0165","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103999_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.03.067","article-title":"Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases","volume":"88","author":"Andleeb","year":"2019","journal-title":"Bioorg Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.103999_b0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1021\/acsmedchemlett.7b00428","article-title":"Structure-based virtual screening for the discovery of novel inhibitors of New Delhi Metallo-beta-lactamase-1","volume":"9","author":"Spyrakis","year":"2018","journal-title":"ACS. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103999_b0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking!","volume":"36","author":"Chen","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2020.103999_b0160","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2020.103999_b0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert. Opin. Drug. Discov."},{"issue":"10","key":"10.1016\/j.bioorg.2020.103999_b0170","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1021\/acs.jcim.7b00412","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations: a cross-docking study","volume":"57","author":"Liu","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"22","key":"10.1016\/j.bioorg.2020.103999_b0175","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1021\/ja003834q","article-title":"Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA","volume":"123","author":"Wang","year":"2001","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.bioorg.2020.103999_b0180","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1128\/AAC.00793-15","article-title":"Emergence of H7N9 influenza A virus resistant to neuraminidase inhibitors in nonhuman primates","volume":"59","author":"Itoh","year":"2015","journal-title":"Antimicrob. Agents. Chemother"},{"issue":"21","key":"10.1016\/j.bioorg.2020.103999_b0185","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1021\/jm400918s","article-title":"Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational\/experimental study","volume":"56","author":"Lecka","year":"2013","journal-title":"J. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2020.103999_h0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"1997","journal-title":"Ad. Drug. Deliv. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2020.103999_h0220","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem."},{"key":"10.1016\/j.bioorg.2020.103999_h0225","first-page":"380","article-title":"Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks","volume":"45","author":"Edwards","year":"2010","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103999_h0230","first-page":"421","article-title":"Drug interactions due to cytochrome P450","volume":"13","author":"Ogu","year":"2000","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"key":"10.1016\/j.bioorg.2020.103999_h0235","series-title":"Comprehensive Toxicology","author":"Obach","year":"2010"},{"key":"10.1016\/j.bioorg.2020.103999_h0240","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.ica.2009.02.012","volume":"362","author":"Kaczmarek","year":"2009","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bioorg.2020.103999_h0245","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1039\/c3dt32740j","volume":"42","author":"Adams","year":"2013","journal-title":"Dalton Trans"},{"key":"10.1016\/j.bioorg.2020.103999_h0250","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1007\/s00044-012-0452-9","volume":"9","author":"Bhat","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"13","key":"10.1016\/j.bioorg.2020.103999_b0200","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1039\/C9RA10692H","article-title":"Biferrocenyl Schiff bases as efficient corrosion inhibitors for an aluminium alloy in HCl solution: a combined experimental and theoretical study","volume":"10","author":"Nazir","year":"2020","journal-title":"RSC Advances"},{"key":"10.1016\/j.bioorg.2020.103999_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127104","article-title":"Experimental and theoretical studies of the schiff base (Z)-1-(thiophen-2-yl-methyleneamino) propane-2-ol","volume":"1200","author":"Berhanu","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"14","key":"10.1016\/j.bioorg.2020.103999_b0210","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1080\/00958972.2018.1482488","article-title":"Bio-conjugated N-(2-hydroxy-1-naphthaldehyde)-glucosamine Cu (II) complex: bacterial sensitivity and superoxide dismutase-like activity","volume":"71","author":"Mir","year":"2018","journal-title":"J. Coord. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2020.103999_b0215","first-page":"639","article-title":"Schiff base of isoniazid and ketoprofen: synthesis, X-ray crystallographic, spectroscopic, antioxidant, and computational studies","volume":"42","author":"Rehman","year":"2018","journal-title":"Turk. J. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103999_h0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5923\/j.chemistry.20120202.09","article-title":"Thiocarbohydrazides: Synthesis and reactions","volume":"2","author":"Metwally","year":"2012","journal-title":"Am. J. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2020.103999_h0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.farmac.2003.11.002","article-title":"Synthesis of 5-(2-,3- and 4-methoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity","volume":"59","author":"Labanauskas","year":"2004","journal-title":"Farmaco."},{"key":"10.1016\/j.bioorg.2020.103999_h0285","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.bmcl.2014.07.013","article-title":"Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1","volume":"24","author":"Bravo","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103999_h0290","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1432-1033.1994.tb20068.x","article-title":"Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities","volume":"226","author":"Belli","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2020.103999_h0295","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/geno.1997.4949","article-title":"Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a new member of the human phosphodiesterase I genes","volume":"45","author":"Jinhua","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.bioorg.2020.103999_b0230","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11302-005-6217-x","article-title":"Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8","volume":"1","author":"Kukulski","year":"2005","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bioorg.2020.103999_b0235","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2020.103999_b0240","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/nprot.2010.86","article-title":"High-throughput screening of tissue-nonspecific alkaline phosphatase for identification of effectors with diverse modes of action","volume":"5","author":"Sergienko","year":"2010","journal-title":"Nat. Protoc."},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2020.103999_b0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta. Crystallogr. D. Biol. Crystallogr"},{"issue":"13","key":"10.1016\/j.bioorg.2020.103999_b0250","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1093\/nar\/gkg512","article-title":"CASTp: computed atlas of surface topography of proteins","volume":"31","author":"Dundas","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.bioorg.2020.103999_b0255","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2020.103999_b0260","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2020.103999_b0265","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2020.103999_b0270","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys"},{"issue":"6","key":"10.1016\/j.bioorg.2020.103999_b0275","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/ct700119m","article-title":"Clustering molecular dynamics trajectories: 1. Characterizing the Performance of different clustering algorithms","volume":"3","author":"Shao","year":"2007","journal-title":"J. Chem. Theory. Comput."},{"key":"10.1016\/j.bioorg.2020.103999_b0280","series-title":"Gaussian 16, Revision C.01","author":"Frisch","year":"2016"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820312967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820312967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:07:16Z","timestamp":1758614836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820312967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":70,"alternative-id":["S0045206820312967"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103999","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and computational studies of highly selective inhibitors of human recombinant tissue non-specific alkaline phosphatase (h-TNAP): A therapeutic target against vascular calcification","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103999"}}